Chemours
485 hedge funds and large institutions have $2.72B invested in Chemours in 2022 Q3 according to their latest regulatory filings, with 47 funds opening new positions, 161 increasing their positions, 152 reducing their positions, and 68 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less funds holding in top 10
Funds holding in top 10: →
23% less capital invested
Capital invested by funds: $3.54B → $2.72B (-$824M)
31% less first-time investments, than exits
New positions opened: 47 | Existing positions closed: 68
37% less call options, than puts
Call options by funds: $45M | Put options by funds: $71.7M
Holders
485
Holding in Top 10
6
Calls
$45M
Puts
$71.7M
Top Buyers
| 1 | +$24.7M | |
| 2 | +$23.3M | |
| 3 | +$23M | |
| 4 |
JP Morgan Chase
New York
|
+$16.1M |
| 5 |
AWAM
Appian Way Asset Management
New York
|
+$15.4M |
Top Sellers
| 1 | -$64.9M | |
| 2 | -$54.4M | |
| 3 | -$22.4M | |
| 4 |
Invesco
Atlanta,
Georgia
|
-$21.1M |
| 5 |
Allianz Asset Management
Munich,
Germany
|
-$17M |